A clinically applicable method for scoring functionally relevant centrosome aberrations by IHC, based on the area of pericentrin stained foci, was recently developed and validated in breast cancer tissues and cell line FFPE sectional pellets [18]. This evidence concerns the gene PCNT and breast carcinoma.